Christine Laronga1, Jhanelle E Gray2, Erin M Siegel3, Ji-Hyun Lee4, William J Fulp4, Michelle Fletcher5, Fred Schreiber6, Richard Brown7, Richard Levine8, Thomas Cartwright9, Guillermo Abesada-Terk10, George Kim11, Carlos Alemany12, Douglas Faig13, Phillip Sharp14, Merry-Jennifer Markham15, David Shibata16, Mokenge Malafa16, Paul B Jacobsen5. 1. Department of Women's Oncology, Tampa, FL. Electronic address: christine.laronga@moffitt.org. 2. Department of Thoracic Oncology, Tampa, FL. 3. Department of Cancer Epidemiology, Tampa, FL. 4. Department of Biostatistics, Tampa, FL. 5. Department of Health Outcomes and Behavior, Tampa, FL. 6. Center for Cancer Care & Research/Watson Clinic, Lakeland, FL. 7. Florida Cancer Specialists/Sarasota Memorial Hospital, Sarasota, FL. 8. Space Coast Medical Associates, Titusville, FL. 9. Florida Cancer Affiliates, Ocala, FL. 10. Robert & Carol Weissman Cancer Center at Martin Memorial, Stuart, FL. 11. Mayo Clinic, Jacksonville, FL. 12. Florida Institute of Research, Medicine & Surgery, Orlando, FL. 13. North Broward Medical Center, Deerfield Beach, FL. 14. Tallahassee Memorial Healthcare, Tallahassee, FL. 15. University of Florida/Shands Cancer Center, Gainesville, FL. 16. Department of Gastrointestinal Oncology, Tampa, FL.
Abstract
BACKGROUND: The Florida Initiative for Quality Cancer Care (FIQCC), composed of 11 practice sites across Florida, conducted its initial evaluation of adherence to breast cancer quality of care indicators (QCI) in 2006, with feedback provided to encourage quality improvement efforts at participating sites. In this study, our objective was to reassess changes over time resulting from these efforts. STUDY DESIGN: Quality care indicators were derived from the Quality Oncology Practice Initiative, the National Comprehensive Cancer Network, the American College of Surgeons, and expert panel consensus. Medical records were reviewed for breast cancer patients first seen by medical oncologists in 2009 at the FIQCC sites, using the same performance indicators as in 2006. Statistical comparisons of 2006 vs 2009 data across sites were made by Pearson chi-square exact test using Monte Carlo estimation. RESULTS: Charts of 602 patients in 2006 and 636 patients in 2009 were compared. Performance on medical oncology QCI improved over time for documentation of clinical trial participation discussion (p = 0.001), documentation of consent for chemotherapy (p = 0.047), definitive surgery done after neoadjuvant chemotherapy (p = 0.017), and planned dose of chemotherapy consistent with published regimens (p = 0.02). Improvements in surgical QCI were seen for documentation of specimen orientation (p < 0.001), inking of margins (p < 0.0001), and performance of sentinel lymph node biopsy (p = 0.035). CONCLUSIONS: The 2006 FIQCC study identified several medical and surgical oncology QCI improvement needs. Quality improvement efforts resulted in better performance for numerous metrics, therefore speaking to the benefits of reassessment of adherence to performance indicators to guide QCI efforts.
BACKGROUND: The Florida Initiative for Quality Cancer Care (FIQCC), composed of 11 practice sites across Florida, conducted its initial evaluation of adherence to breast cancer quality of care indicators (QCI) in 2006, with feedback provided to encourage quality improvement efforts at participating sites. In this study, our objective was to reassess changes over time resulting from these efforts. STUDY DESIGN: Quality care indicators were derived from the Quality Oncology Practice Initiative, the National Comprehensive Cancer Network, the American College of Surgeons, and expert panel consensus. Medical records were reviewed for breast cancerpatients first seen by medical oncologists in 2009 at the FIQCC sites, using the same performance indicators as in 2006. Statistical comparisons of 2006 vs 2009 data across sites were made by Pearson chi-square exact test using Monte Carlo estimation. RESULTS: Charts of 602 patients in 2006 and 636 patients in 2009 were compared. Performance on medical oncology QCI improved over time for documentation of clinical trial participation discussion (p = 0.001), documentation of consent for chemotherapy (p = 0.047), definitive surgery done after neoadjuvant chemotherapy (p = 0.017), and planned dose of chemotherapy consistent with published regimens (p = 0.02). Improvements in surgical QCI were seen for documentation of specimen orientation (p < 0.001), inking of margins (p < 0.0001), and performance of sentinel lymph node biopsy (p = 0.035). CONCLUSIONS: The 2006 FIQCC study identified several medical and surgical oncology QCI improvement needs. Quality improvement efforts resulted in better performance for numerous metrics, therefore speaking to the benefits of reassessment of adherence to performance indicators to guide QCI efforts.
Authors: Pascal James Imperato; Jerry Waisman; Marcia Wallen; Veronica Pryor; Mary Rojas; Kathleen Giardelli; Maryanne Daley Journal: J Community Health Date: 2002-02
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Carlos Alemany; Guillermo Abesada-Terk; Richard Brown; Thomas Cartwright; Douglas Faig; George Kim; Richard Levine; Merry-Jennifer Markham; Fred Schreiber; Philip Sharp; Mokenge Malafa Journal: Psychooncology Date: 2010-09-27 Impact factor: 3.894
Authors: Michael N Neuss; Christopher E Desch; Kristen K McNiff; Peter D Eisenberg; Dean H Gesme; Joseph O Jacobson; Mohammad Jahanzeb; Jennifer J Padberg; John M Rainey; Jeff J Guo; Joseph V Simone Journal: J Clin Oncol Date: 2005-08-08 Impact factor: 44.544
Authors: Michael O Idowu; Leonas G Bekeris; Stephen Raab; Stephen G Ruby; Raouf E Nakhleh Journal: Arch Pathol Lab Med Date: 2010-07 Impact factor: 5.534
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Mihaela Druta; Ji-Hyun Lee; Jan Marshburn; Linda Davenport; Hugh Cruse; Richard Levine; Avantica Gondi; Richard Brown; Mokenge Malafa Journal: J Oncol Pract Date: 2007-03 Impact factor: 3.840
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; Carlos A Alemany; Richard Brown; Thomas H Cartwright; Richard M Levine; Jesusa Corazon R Smith; Guillermo Abesada-Terk; Mokenge P Malafa Journal: Cancer Control Date: 2009-10 Impact factor: 3.302
Authors: Erin M Siegel; Paul B Jacobsen; Mokenge Malafa; William Fulp; Michelle Fletcher; Ji-Hyun Lee; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata Journal: J Oncol Pract Date: 2012-06-12 Impact factor: 3.840
Authors: Timothy Kubal; Doug G Letson; Alberto A Chiappori; Gregory M Springett; Riti Shimkhada; Diana Tamondong Lachica; John W Peabody Journal: BMJ Open Date: 2016-09-13 Impact factor: 2.692
Authors: Carmen van Dooijeweert; Paul J van Diest; Inge O Baas; Elsken van der Wall; Ivette A G Deckers Journal: Diagn Pathol Date: 2020-05-11 Impact factor: 2.644